Terms: = Head and neck cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Treatment
139 results:
1. Inhibition of SUV39H1 reduces tumor angiogenesis via notch1 in oral squamous cell carcinoma.
Chen Y; Weng X; Zhang C; Wang S; Wu X; Cheng B
PeerJ; 2024; 12():e17222. PubMed ID: 38650654
[TBL] [Abstract] [Full Text] [Related]
2. An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
Zhang Y; Du H; Wang N; Wang L; Huang Y
BMC Cancer; 2024 Jan; 24(1):129. PubMed ID: 38267901
[TBL] [Abstract] [Full Text] [Related]
3. Anti-notch1 therapy with OMP-52 M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis.
Li R; Hu Z; Qiao Q; Zhou D; Sun M
Toxicol Appl Pharmacol; 2024 Mar; 484():116825. PubMed ID: 38253083
[TBL] [Abstract] [Full Text] [Related]
4. PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
Ferrarotto R; Swiecicki PL; Zandberg DP; Baiocchi RA; Wesolowski R; Rodriguez CP; McKean M; Kang H; Monga V; Nath R; Palmisiano N; Babbar N; Sun W; Hanna GJ
Oral Oncol; 2024 Feb; 149():106634. PubMed ID: 38118249
[TBL] [Abstract] [Full Text] [Related]
5. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell sequencing reveals SATB2/notch1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Zhang W; Wang J; Huang D; Liu Z; Lu T; Cui C; Li Z
Mol Carcinog; 2024 Jan; 63(1):22-33. PubMed ID: 37877736
[TBL] [Abstract] [Full Text] [Related]
7. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract] [Full Text] [Related]
8. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract] [Full Text] [Related]
9. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
Wang D; Liu J; Chen Y; Jia L; Zhao K; He X
Environ Toxicol; 2024 Feb; 39(2):539-550. PubMed ID: 37347555
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Genome profile testing in head and neck cancer.
Kuroki M; Iinuma R; Okuda H; Terazawa K; Shibata H; Mori KI; Ohashi T; Makiyama A; Futamura M; Miyazaki T; Horikawa Y; Ogawa T
Auris Nasus Larynx; 2023 Dec; 50(6):952-959. PubMed ID: 37164815
[TBL] [Abstract] [Full Text] [Related]
11. Development of a novel prognostic signature derived from essential genes in head and neck squamous cell carcinoma.
Dai Y; Yao Q; Wang Z; Diao P; Wang D; Yan E; Wang Y
J Oral Pathol Med; 2023 Aug; 52(7):610-618. PubMed ID: 37098725
[TBL] [Abstract] [Full Text] [Related]
12. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical notch1 pathway.
Zhou MJ; Yang JJ; Ma TY; Feng GX; Wang XL; Wang LY; Ge YZ; Gao R; Liu HL; Shan L; Kong L; Chen XH
Exp Mol Med; 2023 Mar; 55(3):597-611. PubMed ID: 36879115
[TBL] [Abstract] [Full Text] [Related]
13. Splicing factor SNRPA associated with microvascular invasion promotes hepatocellular carcinoma metastasis through activating notch1/Snail pathway and is mediated by circSEC62/miR-625-5p axis.
Mo Z; Li R; Cao C; Li Y; Zheng S; Wu R; Xue J; Hu J; Meng H; Zhai H; Huang W; Zheng F; Zhou B
Environ Toxicol; 2023 May; 38(5):1022-1037. PubMed ID: 36715182
[TBL] [Abstract] [Full Text] [Related]
14. notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth.
Abby E; Dentro SC; Hall MWJ; Fowler JC; Ong SH; Sood R; Herms A; Piedrafita G; Abnizova I; Siebel CW; Gerstung M; Hall BA; Jones PH
Nat Genet; 2023 Feb; 55(2):232-245. PubMed ID: 36658434
[TBL] [Abstract] [Full Text] [Related]
15.
Coleman N; Marcelo KL; Hopkins JF; Khan NI; Du R; Hong L; Park E; Balsara B; Leoni M; Pickering C; Myers J; Heymach J; Albacker LA; Hong D; Gillison M; Le X
JCO Precis Oncol; 2023 Jan; 7():e2200211. PubMed ID: 36603172
[TBL] [Abstract] [Full Text] [Related]
16. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas.
Gupta AK; Kumar M
Cancer Biomark; 2023; 36(1):31-52. PubMed ID: 36245368
[TBL] [Abstract] [Full Text] [Related]
17. Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma.
Xu X; Wang Y; Bai Y; Lu J; Guo Y; Wang X; Rong L; Tang J; Ma X; Ma J; Zhang L
Front Immunol; 2022; 13():1001173. PubMed ID: 36119057
[TBL] [Abstract] [Full Text] [Related]
18. Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
Feeney L; Hapuarachi B; Adderley H; Rack S; Morgan D; Walker R; Rauch R; Herz E; Kaye J; Harrington K; Metcalf R
Oral Oncol; 2022 Oct; 133():106028. PubMed ID: 35952580
[TBL] [Abstract] [Full Text] [Related]
19. AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling.
Ferrarotto R; Mishra V; Herz E; Yaacov A; Solomon O; Rauch R; Mondshine A; Motin M; Leibovich-Rivkin T; Davis M; Kaye J; Weber CR; Shen L; Pearson AT; Rosenberg AJ; Chen X; Singh A; Aster JC; Agrawal N; Izumchenko E
Cell Death Dis; 2022 Aug; 13(8):678. PubMed ID: 35931701
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
[TBL] [Abstract] [Full Text] [Related]
[Next]
